The proposed study will investigate the function of quiescent leukemic cells in non B - non T acute lymphoblastic leukemia in children. In multivariate analysis of prognostic factors, and in sequential studies in patients, quiescent cells with low cellular RNA content have been identified as resistant to early induction therapy. They may also constitute the source of leukemic cells at relapse. Cellular DNA content, RNA content and the expression of specific proteins involved in cell cycle regulation (s30 """"""""statin"""""""", PCNA, p53, histone HI-0, transferrin receptor) will be studied by new flow cytometric techniques and their interactions will be investigated. Quiescent cells will be separated by fluorescence activated cell sortin for further morphological and immunological evaluations. Recent data indicate the complete differentiation of a small subpopulation of leukemic """"""""null"""""""" cells to mature B cells in untreated patients. These cells are quiescent and preliminary studies indicate their resistance to chemotherapy. Multiparameter flow cytometric analysis of cell surface immunoglobulin light chain expression, DNA, and RNA content will elucidate the relationship between subgroups of quiescent and differentiated leukemic cells. Sorted subpopulations with differences in RNA content and immunoglobulin expression will be analyzed for heavy and light chain gene rearrangements and transcription of the rearranged genes. A model will be developed to better define the prognostic importance of quiescent/differentiated cells in pediatric ALL. In vitro studies will attempt to recruit quiescent cells into the cell cycle and render them more sensitive to induction therapy. If the studies are successful, patients at increased risk of relapse will be identified at diagnosis and new therapeutic modalities could be developed.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA041305-01
Application #
3181661
Study Section
Pathology B Study Section (PTHB)
Project Start
1986-04-01
Project End
1989-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Zhao, S; Consoli, U; Arceci, R et al. (1996) Semi-automated PCR method for quantitating MDR1 expression. Biotechniques 21:726-31
Escudier, S M; Albitar, M; Robertson, L E et al. (1996) Acute lymphoblastic leukemia following preleukemic syndromes in adults. Leukemia 10:473-7
Andreeff, M; Tafuri, A; Hegewisch-Becker, S (1990) Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance the cytotoxic effects of cytosine-arabinoside. Haematol Blood Transfus 33:747-62
Redner, A; Hegewisch, S; Haimi, J et al. (1990) A study of multidrug resistance and cell kinetics in a child with near-haploid acute lymphoblastic leukemia. Leuk Res 14:771-7
Paietta, E; Andreeff, M; Papenhausen, P et al. (1989) Distinct antigen expression related to DNA ploidy in a case of biphenotypic leukemia. Leukemia 3:76-8
Albino, A P; Nanus, D M; Mentle, I R et al. (1989) Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene 4:1363-74
Andreeff, M; Welte, K (1989) Hematopoietic colony-stimulating factors. Semin Oncol 16:211-29
Gaynor, J; Chapman, D; Little, C et al. (1988) A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969. J Clin Oncol 6:1014-30
Kong, X B; Andreeff, M; Fanucchi, M P et al. (1987) Cell differentiation effects of 2'-fluoro-1-beta-D-arabinofuranosyl pyrimidines in HL-60 cells. Leuk Res 11:1031-9
Andreeff, M (1986) Cell kinetics of leukemia. Semin Hematol 23:300-14